SR, Z., LC, Z., YP, J., J, Z., RJ, X., YS, X., . . . SL, M. (2025). Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice. Acta pharmacologica Sinica, 46(8), 2336. https://doi.org/10.1038/s41401-025-01542-6
Chicago Style (17th ed.) CitationSR, Zhang, Zhu LC, Jiang YP, Zhang J, Xu RJ, Xu YS, Xia B, and Ma SL. "Correction: Efficacy of Afatinib, an Irreversible ErbB Family Blocker, in the Treatment of Intracerebral Metastases of Non-small Cell Lung Cancer in Mice." Acta Pharmacologica Sinica 46, no. 8 (2025): 2336. https://doi.org/10.1038/s41401-025-01542-6.
MLA (9th ed.) CitationSR, Zhang, et al. "Correction: Efficacy of Afatinib, an Irreversible ErbB Family Blocker, in the Treatment of Intracerebral Metastases of Non-small Cell Lung Cancer in Mice." Acta Pharmacologica Sinica, vol. 46, no. 8, 2025, p. 2336, https://doi.org/10.1038/s41401-025-01542-6.